Tricuspid stenosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(13 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Tricuspid stenosis}}
{{Tricuspid stenosis}}
{{CMG}}
{{CMG}} {{AE}} [[User:Mohammed Salih|Mohammed Salih, M.D.]] {{sali}}


==Overview==
==Overview==
[[Tricuspid stenosis]] ([[TS]]) is the least common [[Valvular Heart Disease|valvular]] disease. TS is rarely an isolated disease, it is mostly associated with [[mitral valve]] and/or [[aortic]] valve abnormalities.  Approximately 8% of patients with [[rheumatic heart disease]] develop isolated TS, while up to 50% develop [[tricuspid regurgitation]] and TS. The [[prevalence]] of TS is lower in developed countries compared to developing countries due to the low prevalence of [[rheumatic heart disease]], which is the most common cause of TS.


==Epidemiology and Demographics==
==Epidemiology and Demographics==


===Prevalence===
=== Incidence ===
TS is the least common valvular disease. Among patient with rheumatic heart disease, it was reported that approximately 8% develop isolated TS, while up to 50% develop [[tricuspid regurgitation]] and TS.<ref name="pmid10636636">{{cite journal| author=Goswami KC, Rao MB, Dev V, Shrivastava S| title=Juvenile tricuspid stenosis and rheumatic tricuspid valve disease: an echocardiographic study. | journal=Int J Cardiol | year= 1999 | volume= 72 | issue= 1 | pages= 83-6 | pmid=10636636 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10636636  }} </ref>


The prevalence of TS in developed countries is low due to the low prevalence of [[rheumatic heart disease]], the most common cause of TS. The prevalence of TS is higher in developing countries due tot the higher prevalence of [[rheumatic heart disease]].
*United States data shows that tricuspid stenosis is rare, occurring in less than 1% of the population.
*While found in approximately 15% of patients with [[rheumatic heart disease]] at [[autopsy]], it is estimated to be clinically significant in only 5% of these patients.  
*The [[incidence]] of the [[congenital]] form of the disease is less than 1%.<ref name="pmid10636636">{{cite journal| author=Goswami KC, Rao MB, Dev V, Shrivastava S| title=Juvenile tricuspid stenosis and rheumatic tricuspid valve disease: an echocardiographic study. | journal=Int J Cardiol | year= 1999 | volume= 72 | issue= 1 | pages= 83-6 | pmid=10636636 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10636636  }} </ref>
*[[Tricuspid stenosis]] is found in approximately 3% of the international population.
*[[Tricuspid stenosis]] is more prevalent in areas with a high [[incidence]] of [[rheumatic fever]].<ref name="pmid24973838">{{cite journal |vauthors=Manjunath CN, Srinivas P, Ravindranath KS, Dhanalakshmi C |title=Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience |journal=Indian Heart J |volume=66 |issue=3 |pages=320–6 |date=2014 |pmid=24973838 |pmc=4121759 |doi=10.1016/j.ihj.2014.03.010 |url=}}</ref><ref name="pmid28131996">{{cite journal |vauthors=Marciniak A, Glover K, Sharma R |title=Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK |journal=BMJ Open |volume=7 |issue=1 |pages=e012240 |date=January 2017 |pmid=28131996 |pmc=5278264 |doi=10.1136/bmjopen-2016-012240 |url=}}</ref>


===Mortality/Morbidity===
===Age===
*Mortality is dependent upon the precipitating cause
*[[Tricuspid stenosis]] can present as a [[congenital]] lesion or later in life when it is due to some other condition.
*Mortality rate is 5%
*The [[congenital]] form accounts for approximately 0.3% of all [[congenital heart disease]] cases.
*The frequency of [[tricuspid stenosis]] in the older population, due to secondary causes, ranges from 0.3-3.2%
 
===Gender===
*[[Tricuspid stenosis]] is observed more commonly in women than in men, similar to [[mitral stenosis]] of [[rheumatic]] origin.
*The [[congenital]] form of the disease has a slightly higher male predominance.


===Race===
===Race===
There does not seem to be any racial predisposition
*No racial predisposition is apparent.
 
===Sex===
*Observed more in women
*Congenital form is slightly more prevalent in men
 
===Age===
*Congenital form accounts for 0.3% of all congenital heart diseases
*Due to secondary causes, in the older population, frequency is between 0.3 - 3.2%


==References==
==References==
Line 32: Line 33:
{{Circulatory system pathology}}
{{Circulatory system pathology}}
{{Congenital malformations and deformations of circulatory system}}
{{Congenital malformations and deformations of circulatory system}}
[[Category: Valvular heart disease]]
[[Category:Disease]]
[[Category:Cardiology]]


{{WH}}


{{WS}}
{{WH}}{{WS}}

Latest revision as of 21:32, 1 April 2020

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis epidemiology and demographics

CDC on Tricuspid stenosis epidemiology and demographics

Tricuspid stenosis epidemiology and demographics in the news

Blogs on Tricuspid stenosis epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Salih, M.D. Syed Musadiq Ali M.B.B.S.[2]

Overview

Tricuspid stenosis (TS) is the least common valvular disease. TS is rarely an isolated disease, it is mostly associated with mitral valve and/or aortic valve abnormalities. Approximately 8% of patients with rheumatic heart disease develop isolated TS, while up to 50% develop tricuspid regurgitation and TS. The prevalence of TS is lower in developed countries compared to developing countries due to the low prevalence of rheumatic heart disease, which is the most common cause of TS.

Epidemiology and Demographics

Incidence

Age

Gender

Race

  • No racial predisposition is apparent.

References

  1. Goswami KC, Rao MB, Dev V, Shrivastava S (1999). "Juvenile tricuspid stenosis and rheumatic tricuspid valve disease: an echocardiographic study". Int J Cardiol. 72 (1): 83–6. PMID 10636636.
  2. Manjunath CN, Srinivas P, Ravindranath KS, Dhanalakshmi C (2014). "Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience". Indian Heart J. 66 (3): 320–6. doi:10.1016/j.ihj.2014.03.010. PMC 4121759. PMID 24973838.
  3. Marciniak A, Glover K, Sharma R (January 2017). "Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK". BMJ Open. 7 (1): e012240. doi:10.1136/bmjopen-2016-012240. PMC 5278264. PMID 28131996.


Template:WHTemplate:WS